Literature DB >> 27664934

Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency.

Reza Yazdani1, Mazdak Ganjalikhani-Hakemi2, Mohammad Esmaeili3, Hassan Abolhassani4, Shahram Vaeli3, Abbas Rezaei5, Zohre Sharifi3, Gholamreza Azizi6, Nima Rezaei7, Asghar Aghamohammadi8.   

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous group of primary immunodeficiency characterized by recurrent infections. We evaluated whether defective PI3K/Akt/FoxO pathway could influence B-cell fate. Determination of B-cell subsets in CVD patients and healthy donors (HDs) were performed using flow cytometry. We evaluated mRNA and protein expression of PI3K, Akt and FoxO using real-time PCR and flow cytometry, respectively. Moreover, phosphorylated Akt (pAkt) expression in B-cells has been measured by flowcytometry. We identified a significant reduction in the percentage of marginal zone like B-cells, memory B-cells (total, switched and unswitched) and plasmablasts in patients, as these decreased B-cell subsets had a significant negative correlation with increased apoptosis in patients. Surprisingly, we identified decreased pAkt expression in B-cells of patients than HDs. We described for the first time impaired pAkt expression in B-cells of CVID patients that had a significant correlation with antibody response to the vaccine and worse clinical complications.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody response; B-cell; Common variable immunodeficiency; PI3K/Akt/FoxO pathway; Phosphorylated Akt

Mesh:

Substances:

Year:  2016        PMID: 27664934     DOI: 10.1016/j.clim.2016.09.009

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

1.  The BANK1 SLE-risk variants are associated with alterations in peripheral B cell signaling and development in humans.

Authors:  Elizabeth M Dam; Tania Habib; Janice Chen; Andrew Funk; Veronika Glukhova; Mel Davis-Pickett; Shan Wei; Richard James; Jane H Buckner; Karen Cerosaletti
Journal:  Clin Immunol       Date:  2016-11-02       Impact factor: 3.969

2.  The Immunogenetics of Systemic Sclerosis.

Authors:  Begüm Ünlü; Ümit Türsen; Zeynab Rajabi; Navid Jabalameli; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Immunogenetics of Lupus Erythematosus.

Authors:  Begüm Ünlü; Ümit Türsen; Navid Jabalameli; Fahimeh Abdollahimajd; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  B- and T-Cell Subset Abnormalities in Monogenic Common Variable Immunodeficiency.

Authors:  Saba Fekrvand; Shaghayegh Khanmohammadi; Hassan Abolhassani; Reza Yazdani
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

5.  The role and mechanism of miR-557 in inhibiting the differentiation and maturation of megakaryocytes in immune thrombocytopenia.

Authors:  Yan Wang; Yujie Guo; Xiaolei Zhang; Hui Zhao; Bingbing Zhang; Yi Wu; Jingyu Zhang
Journal:  RNA Biol       Date:  2021-02-15       Impact factor: 4.652

6.  Compressional-Puffing Pretreatment Enhances Neuroprotective Effects of Fucoidans from the Brown Seaweed Sargassum hemiphyllum on 6-Hydroxydopamine-Induced Apoptosis in SH-SY5Y Cells.

Authors:  Chun-Yung Huang; Chia-Hung Kuo; Po-Wei Chen
Journal:  Molecules       Date:  2017-12-29       Impact factor: 4.411

7.  Mapping of Signaling Pathways Linked to sIgAD Reveals Impaired IL-21 Driven STAT3 B-Cell Activation.

Authors:  Andri L Lemarquis; Fannar Theodors; Helga K Einarsdottir; Bjorn R Ludviksson
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

8.  Dysregulated PI3K Signaling in B Cells of CVID Patients.

Authors:  Ina Harder; Matthias Münchhalfen; Geoffroy Andrieux; Melanie Boerries; Bodo Grimbacher; Hermann Eibel; Maria Elena Maccari; Stephan Ehl; Jürgen Wienands; Julia Jellusova; Klaus Warnatz; Baerbel Keller
Journal:  Cells       Date:  2022-01-28       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.